Therapeutic strategies in nonalcoholic fatty liver disorders

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in developing countries. Many of the risk factors are well defined, but the underlying pathogenesis is not well understood. The demographics of the condition mirror those of the metabolic syndrome, with obesity and insulin resistance being the most commonly associated conditions. At present, therapy is aimed at correcting the risk factors, but there are no proven therapies at this point.

Original languageEnglish (US)
Pages (from-to)237-239
Number of pages3
JournalExpert Opinion on Emerging Drugs
Issue number2
StatePublished - May 2005
Externally publishedYes


  • Fatty liver
  • NASH
  • Steatohepatitis
  • Steatosis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology


Dive into the research topics of 'Therapeutic strategies in nonalcoholic fatty liver disorders'. Together they form a unique fingerprint.

Cite this